Results Review Note (Herbal Medicine)

Date of Review: [Date of review (YYYY-MM-DD)]

Date Results Available: [Date results available (YYYY-MM-DD) / same as review date]

Provider: [Provider full name, credentials]

Clinic/Service: [Clinic or service name]

Mode of Review: [chart review only / patient contact - phone / patient contact - video / patient contact - secure message / patient contact - in-person]

Reason for Review

[Reason for review and clinical question being addressed] (One to three sentences identifying the trigger—routine herbal regimen monitoring, outside lab upload, abnormal result, post-imaging follow-up—and the clinical question. If unclear from available records, state that explicitly.)

Results Reviewed

(Summarize clinically relevant content only. Present abnormal values first with units and reference ranges, then relevant normal findings. Distinguish between finalized report review and independent interpretation. Include trends when clinically important. Note data limitations if applicable. Attach complete reports rather than pasting full text.)

(Repeat block for each data source reviewed.)

• Data Type: [lab / imaging / pathology / other] | Source: [Facility name] | Collection Date: [YYYY-MM-DD] | Review Type: [finalized report reviewed / independent interpretation]

  • Key Abnormal Findings: [Abnormal results with values, units, and reference ranges, ordered by clinical significance / none]
  • Relevant Normal Findings: [Normal results informing the clinical question] (Include only if relevant.)
  • Trend Comparison: [Trend versus prior results with dates] (Include only when clinically important.)
  • Data Limitations: [Limitations such as scanned PDF missing ranges, hemolyzed specimen] (Include if applicable.)

Clinical Context & Herbal Regimen

(Provide minimum context for safe interpretation. Document "unknown" explicitly for critical safety factors that cannot be confirmed.)

• Relevant Diagnoses & Treatment Goals: [Diagnoses and goals relevant to this review]
• Medication/Supplement List Status: [Date of last reconciliation; note if list may be incomplete]
• Pertinent Safety History: [Hepatic or renal disease, bleeding/clotting history, anticoagulant/antiplatelet use, planned procedures, pregnancy/lactation status, allergies or prior supplement reactions, high-risk conventional medications—document each as present, absent, or unknown]

Active or Proposed Herbal Regimen: (List only botanicals relevant to current decision. Repeat block for each.)

• Herb: [Common name] (Botanical: [Latin binomial])
  Preparation/Standardization: [Formulation and standardization if known; state "unknown—label photo requested" if uncertain]
  Dose & Frequency: [Exact dose and schedule] | Start Date: [YYYY-MM-DD / unknown]
  Intended Indication: [Indication]
  Relevant Risk Domain: [hepatotoxicity / nephrotoxicity / bleeding risk / CYP interaction / serotonergic potential / QT prolongation / immunomodulatory / photosensitivity / other]
  Product Identity Certainty: [confirmed via label / patient report only / uncertain]

Assessment & Plan

(Organize by clinical urgency. Use diagnosis when established, descriptive label when not. Tie assessments to specific results with dates. Use "temporal association" rather than asserting causality unless supported by clear evidence.)

[Problem 1]: [Diagnosis or descriptive label]

• Supporting Results: [Specific results with dates informing this assessment]
• Interpretation: [Clinical significance in context of herbal plan; document uncertainties clearly]
• Herbal Regimen Actions: [start / continue / hold / stop / taper] [herb name] [dose, frequency, duration, rationale]
• Conventional Care Actions: [Referrals, medication changes, additional testing, procedures with timing]
• Monitoring Plan: [Parameters, timing for repeat testing, action thresholds]
• Safety Counseling: [Red-flag symptoms and when to seek urgent care]

[Problem 2]: [Diagnosis or descriptive label]

(Include additional problems as applicable using same structure.)

Critical/Time-Sensitive Results: [yes / no] (If yes: document finding, who notified, method, date/time, acknowledgment received, and actions taken. If patient unreachable, document attempts and escalation pathway.)

Communication & Follow-up

• Patient Contact: [contacted / not yet contacted] (If contacted: method, what was explained, patient understanding, agreement with plan. If not yet contacted: notification pathway and timeframe.)
• Responsibility Assignments: [Who will obtain repeat labs, send/receive messages, review results, and by when]
• External Clinician Coordination: [Clinicians notified and handoff details] (Include if applicable.)
• Suspected Supplement-Related Adverse Event: [yes / no] (If yes: symptom timeline relative to product use, response to discontinuation if known, product details including brand/lot, and whether MedWatch reporting was considered or submitted.)

Electronic Signature: [Provider name, credentials, date/time signed]

Addenda: [Dated addenda describing subsequent changes and rationale] (Use for any later updates.)